Chronic aortic regurgitation medical therapy

WikiDoc Resources for Chronic aortic regurgitation medical therapy
Articles
Most recent articles on Chronic aortic regurgitation medical therapy Most cited articles on Chronic aortic regurgitation medical therapy Review articles on Chronic aortic regurgitation medical therapy Articles on Chronic aortic regurgitation medical therapy in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Chronic aortic regurgitation medical therapy Images of Chronic aortic regurgitation medical therapy Photos of Chronic aortic regurgitation medical therapy Podcasts & MP3s on Chronic aortic regurgitation medical therapy Videos on Chronic aortic regurgitation medical therapy
Evidence Based Medicine
Cochrane Collaboration on Chronic aortic regurgitation medical therapy Bandolier on Chronic aortic regurgitation medical therapy TRIP on Chronic aortic regurgitation medical therapy
Clinical Trials
Ongoing Trials on Chronic aortic regurgitation medical therapy at Clinical Trials.gov Trial results on Chronic aortic regurgitation medical therapy Clinical Trials on Chronic aortic regurgitation medical therapy at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Chronic aortic regurgitation medical therapy NICE Guidance on Chronic aortic regurgitation medical therapy NHS PRODIGY Guidance FDA on Chronic aortic regurgitation medical therapy CDC on Chronic aortic regurgitation medical therapy
Books
Books on Chronic aortic regurgitation medical therapy
News
Chronic aortic regurgitation medical therapy in the news Be alerted to news on Chronic aortic regurgitation medical therapy News trends on Chronic aortic regurgitation medical therapy
Commentary
Blogs on Chronic aortic regurgitation medical therapy
Definitions
Definitions of Chronic aortic regurgitation medical therapy
Patient Resources / Community
Patient resources on Chronic aortic regurgitation medical therapy Discussion groups on Chronic aortic regurgitation medical therapy Patient Handouts on Chronic aortic regurgitation medical therapy Directions to Hospitals Treating Chronic aortic regurgitation medical therapy Risk calculators and risk factors for Chronic aortic regurgitation medical therapy
Healthcare Provider Resources
Symptoms of Chronic aortic regurgitation medical therapy Causes & Risk Factors for Chronic aortic regurgitation medical therapy Diagnostic studies for Chronic aortic regurgitation medical therapy Treatment of Chronic aortic regurgitation medical therapy
Continuing Medical Education (CME)
CME Programs on Chronic aortic regurgitation medical therapy
International
Chronic aortic regurgitation medical therapy en Espanol Chronic aortic regurgitation medical therapy en Francais
Business
Chronic aortic regurgitation medical therapy in the Marketplace Patents on Chronic aortic regurgitation medical therapy
Experimental / Informatics
List of terms related to Chronic aortic regurgitation medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Medical therapy of chronic aortic insufficiency involves the use of vasodilators. Small trials have demonstrated a benefit from the administration of ACE inhibitors, nifedipine, sodium nitroprusside and hydralazine in improving left ventricular wall stress, ejection fraction, and left ventricular mass . The use of these vasodilators is indicated only in those individuals who suffer from hypertension in addition to aortic insufficiency. The goal in using these pharmacologic agents is to decrease the afterload so that the left ventricle is unloaded. This results in reduction in left ventricular end diastolic pressure thereby preserving the left ventricular systolic function and also benefits the patients in left ventricular failure secondary to aortic insufficiency.

Long term therapy with nifedipine and hydralazine have shown to increase left ventricular ejection fraction, reduce left ventricular end diastolic volume and reduction in left ventricular mass thereby delaying the need for valve surgery . While ACE inhibitors such as enalapril and quinapril have shown to decrease left ventricular mass and end diastolic volume but with no influence on ejection fraction

Patients with severe aortic insufficiency with normal left ventricular function are recommended to undergo surgery though there are no sufficient evidences against medical management.

Use of drugs other than vasodilators, such as digoxin, diuretics and other positive inotropic drugs for long term treatment have no supporting data. Beta blockers are relatively contraindicated since they decrease heart rate and prolong diastolic phase. There by increasing the back flow of blood from aorta. However beta blockers can be considered in patients with bicuspid aortic valve with mild aortic insufficiency and aortic root diameter of more than 40mm .

ACC/AHA guidelines for use of Vasodilator therapy in Chronic severe Aortic Insufficiency

“

Class I Vasodilator therapy is indicated for chronic therapy in patients with severe aortic insufficiency who have symptoms or left ventricular dysfunction when surgery is not recommended because of additional cardiac or noncardiac factors. Class IIa Vasodilator therapy is reasonable for short-term therapy to improve the hemodynamic profile of patients with severe heart failure symptoms and severe left ventricular dysfunction before proceeding with aortic valve replacement. Class IIb Vasodilator therapy may be considered for long-term therapy in asymptomatic patients with severe aortic insufficiency who have left ventricular dilatation but normal systolic function. Class III Vasodilator therapy is not indicated for long-term therapy in asymptomatic patients with mild to moderate aortic insufficiency and normal left ventricular systolic function. Vasodilator therapy is not indicated for long-term therapy in asymptomatic patients with left ventricular systolic dysfunction who are otherwise candidates for aortic valve replacement. Vasodilator therapy is not indicated for long-term therapy in symptomatic patients with either normal left ventricular function or mild to moderate left ventricular systolic dysfunction who are otherwise candidates for aortic valve replacement.

”

Prophylactic antibiotics prior dental procedures are not recommended for all patients with aortic insufficiency as per 2007 AHA guidelines (for infective endocarditis) unless there are other indications.